Last updated: 16 June 2019 at 6:12pm EST

Mark R Blake Net Worth




The estimated Net Worth of Mark R Blake is at least $5.69 million dollars as of 7 November 2014. Mark Blake owns over 24,668 units of Cardinal Health stock worth over $2,313,360 and over the last 15 years Mark sold CAH stock worth over $3,380,297.

Mark Blake CAH stock SEC Form 4 insiders trading

Mark has made over 12 trades of the Cardinal Health stock since 2012, according to the Form 4 filled with the SEC. Most recently Mark sold 24,668 units of CAH stock worth $1,961,106 on 7 November 2014.

The largest trade Mark's ever made was exercising 38,350 units of Cardinal Health stock on 7 May 2013 worth over $1,070,349. On average, Mark trades about 7,461 units every 32 days since 2009. As of 7 November 2014 Mark still owns at least 20,409 units of Cardinal Health stock.

You can see the complete history of Mark Blake stock trades at the bottom of the page.



What's Mark Blake's mailing address?

Mark's mailing address filed with the SEC is 7000, Cardinal Place, Dublin, Washington Township, Franklin County, Ohio, 43017, United States.

Insiders trading at Cardinal Health

Over the last 23 years, insiders at Cardinal Health have traded over $135,712,519 worth of Cardinal Health stock and bought 2,709 units worth $199,571 . The most active insiders traders include Dean A Scarborough, George S Barrett et Jeffrey William Henderson. On average, Cardinal Health executives and independent directors trade stock every 32 days with the average trade being worth of $5,146,997. The most recent stock trade was executed by Jessica L Mayer on 21 August 2024, trading 16,573 units of CAH stock currently worth $1,812,920.



What does Cardinal Health do?

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.



What does Cardinal Health's logo look like?

Cardinal Health, Inc. logo

Complete history of Mark Blake stock trades at Cardinal Health

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
7 Nov 2014 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 24,668 $79.50 $1,961,106
7 Nov 2014
20,409
15 Aug 2014 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 4,782 $72.15 $345,021
15 Aug 2014
22,589
24 Jul 2014 Mark R Blake
EVP -- Strategy et Corp. Dev.
Exercice d'option 23,114 $40.96 $946,749
24 Jul 2014
47,530
19 May 2014 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 4,703 $66.50 $312,750
19 May 2014
24,416
13 May 2014 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 2,822 $66.50 $187,663
13 May 2014
29,119
11 Feb 2014 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 2,330 $68.53 $159,675
11 Feb 2014
31,941
11 Sep 2013 Mark R Blake
EVP -- Strategy et Corp. Dev.
Exercice d'option 18,214 $30.94 $563,541
11 Sep 2013
48,855
19 Aug 2013 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 4,925 $51.27 $252,505
19 Aug 2013
30,641
5 Aug 2013 Mark R Blake
EVP -- Strategy et Corp. Dev.
Exercice d'option 36,427 $30.94 $1,127,051
5 Aug 2013
61,907
7 May 2013 Mark R Blake
EVP -- Strategy et Corp. Dev.
Exercice d'option 38,350 $27.91 $1,070,349
7 May 2013
56,305
10 Jan 2013 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 1,471 $42.92 $63,135
10 Jan 2013
17,955
14 Dec 2012 Mark R Blake
EVP -- Strategy et Corp. Dev.
Vente 2,330 $42.25 $98,443
14 Dec 2012
19,426


Cardinal Health executives and stock owners

Cardinal Health executives and other stock owners filed with the SEC include: